/ Not yet recruitingPhase 2 A PHASE II, MULTICENTRE, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND TOLERABILITY OF ZD1839 (IRESSA?) IN COMBINATION WITH CASODEX? IN PATIENTS WITH OPERABLE PROSTATE CANCER
100 Clinical Results associated with Astrazeneca Plc /Plankstadt Plant/
0 Patents (Medical) associated with Astrazeneca Plc /Plankstadt Plant/
100 Deals associated with Astrazeneca Plc /Plankstadt Plant/
100 Translational Medicine associated with Astrazeneca Plc /Plankstadt Plant/